Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
Jamila Laoukili, Alexander Constantinides, Emma C. E. Wassenaar, et al.
British Journal of Cancer (2022) Vol. 126, Iss. 12, pp. 1824-1833
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Mechanisms of metastatic colorectal cancer
Adrià Cañellas‐Socias, Elena Sancho, Eduard Batlle
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 609-625
Closed Access | Times Cited: 30
Oxaliplatin and its derivatives – An overview
Paul O'Dowd, Darragh F. Sutcliffe, Darren M. Griffith
Coordination Chemistry Reviews (2023) Vol. 497, pp. 215439-215439
Open Access | Times Cited: 33
The molecular biology of peritoneal metastatic disease
Sanne Bootsma, Maarten F. Bijlsma, Louis Vermeulen
EMBO Molecular Medicine (2023) Vol. 15, Iss. 3
Open Access | Times Cited: 27
Tumor organoid biobank-new platform for medical research
Xuexue Xie, Xinyu Li, Wei Song
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
Lidwien P. Smabers, Emerens Wensink, Carla S. Veríssimo, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 10
Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
Emre Küçükköse, Balthasar A. Heesters, Julien Villaudy, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005345-e005345
Open Access | Times Cited: 37
Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management
Leili Rejali, Romina Seifollahi Asl, Fatemeh Sanjabi, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2746-2746
Open Access | Times Cited: 16
Metastasis organotropism in colorectal cancer: advancing toward innovative therapies
Kai He, Zhihan Wang, Maochao Luo, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by 68Ga-FAPI-PET imaging
Esther Strating, Emma C. E. Wassenaar, Mathijs Verhagen, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 1, pp. 145-155
Open Access | Times Cited: 24
Glutathione-Dependent Pathways in Cancer Cells
Elena Kalinina
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8423-8423
Open Access | Times Cited: 5
Precision Medicine for Peritoneal Carcinomatosis—Current Advances in Organoid Drug Testing and Clinical Applicability
Harleen Kaur, Josephine A. Wright, Daniel L. Worthley, et al.
Organoids (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
Imaging gastric cancer metastasis progression in an organotypic, three-dimensional functional model of the human peritoneum
Arianna Castagna, Frank‐Jürgen Weinreich, Andreas Brandl, et al.
Pleura and Peritoneum (2025)
Closed Access
Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis
Michael G. White, Reed I. Ayabe, Mohammad A. Zeineddine, et al.
Translational Oncology (2025) Vol. 55, pp. 102379-102379
Closed Access
Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients
Jinho Kim, Hyun Jung Kim, Min-Seok Lee, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
SNORA56-mediated pseudouridylation of 28 S rRNA inhibits ferroptosis and promotes colorectal cancer proliferation by enhancing GCLC translation
Chang Xu, Zhixuan Bian, Xinyue Wang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 11
Peritoneal resident macrophages constitute an immunosuppressive environment in peritoneal metastasized colorectal cancer
J. Saris, Andrew Y. F. Li Yim, S. Bootsma, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer
Elisa C. Toffoli, Amanda A. van Vliet, Henk W M Verheul, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e007554-e007554
Open Access | Times Cited: 9
Seed and Soil: Consensus Molecular Subgroups (CMS) and Tumor Microenvironment Features Between Primary Lesions and Metastases of Different Organ Sites in Colorectal Cancer
Qingqing Luo, Yibo Quan, Wei Liu, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 225-243
Open Access | Times Cited: 2
Cancer organoid applications to investigate chemotherapy resistance
K Harada, Naoya Sakamoto
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 12
Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer
Wei Xia, Yiting Geng, Wenwei Hu
Cancers (2023) Vol. 15, Iss. 23, pp. 5641-5641
Open Access | Times Cited: 5
Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study
Anouk Rijken, Vincent C. J. van de Vlasakker, Geert A. Simkens, et al.
Clinical & Experimental Metastasis (2023) Vol. 40, Iss. 4, pp. 289-298
Open Access | Times Cited: 4
Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases
Sanne Bootsma, Mark P.G. Dings, Job Kesselaar, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101523-101523
Open Access | Times Cited: 1
Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases
Pascale C. S. Rietveld, Niels A.D. Guchelaar, Ruben A.G. van Eerden, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116820-116820
Open Access | Times Cited: 1
Clinical significance of circulating tumor cells in colorectal cancer with peritoneal metastases: a prospective cohort study using a novel method for monitoring treatment response, and assessing minimal residual disease
Petter Frühling, Louice Moberg, Lana Ghanipour, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 11, pp. 7187-7195
Closed Access | Times Cited: 1
Metastatic colorectal cancer cells upregulate SMLR1 that interacts with tumor-associated macrophages in the liver
Chi Wut Wong, Lihua Wang, Jorge Prado Balcazar, et al.
(2024), pp. 1-22
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top